GR3020682T3 - Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. - Google Patents

Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.

Info

Publication number
GR3020682T3
GR3020682T3 GR960402040T GR960402040T GR3020682T3 GR 3020682 T3 GR3020682 T3 GR 3020682T3 GR 960402040 T GR960402040 T GR 960402040T GR 960402040 T GR960402040 T GR 960402040T GR 3020682 T3 GR3020682 T3 GR 3020682T3
Authority
GR
Greece
Prior art keywords
dioxabicyclo
cholesterol
metabolism
inhibiting
medicament
Prior art date
Application number
GR960402040T
Other languages
English (en)
Inventor
Kengo Akimoto
Sumio Asami
Michihiro Sugano
Nobuaki Hirose
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17644733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3020682(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of GR3020682T3 publication Critical patent/GR3020682T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR960402040T 1990-10-22 1996-07-31 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. GR3020682T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28183990A JP3183664B2 (ja) 1990-10-22 1990-10-22 コレステロール及び胆汁酸の代謝阻害剤

Publications (1)

Publication Number Publication Date
GR3020682T3 true GR3020682T3 (en) 1996-10-31

Family

ID=17644733

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402040T GR3020682T3 (en) 1990-10-22 1996-07-31 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.

Country Status (9)

Country Link
US (1) US5270335A (el)
EP (1) EP0488513B1 (el)
JP (1) JP3183664B2 (el)
AT (1) ATE138571T1 (el)
CA (1) CA2053820C (el)
DE (1) DE69119875T2 (el)
DK (1) DK0488513T3 (el)
ES (1) ES2087252T3 (el)
GR (1) GR3020682T3 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06227977A (ja) * 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
KR970701043A (ko) * 1994-02-25 1997-03-17 데이비드 키즈키스 항-염증성 및 감염 보호 효과를 갖는 세사민-기본 리그난(anti-inflammatory and infection protective effects of sesamin-based lignans)
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
CN1073825C (zh) * 1995-07-04 2001-10-31 三得利公司 二氧杂二环[3.3.0]辛烷衍生物的新用途
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
US7081260B2 (en) * 2002-10-29 2006-07-25 Council Of Scientific And Industrial Research α-Glucosidase inhibitors from a natural source
AU2006231967B2 (en) 2005-03-31 2011-09-15 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
AU2006295843B2 (en) 2005-09-30 2012-04-12 Suntory Holdings Limited A process and an apparatus for producing episesamin-rich compositions
CN101404996B (zh) 2006-03-31 2011-05-18 三得利控股株式会社 含有木脂素类化合物的组合物
JP4829963B2 (ja) 2006-10-04 2011-12-07 サントリーホールディングス株式会社 リグナン類化合物含有ｏ／ｗ／ｏ型エマルション及びそれを含有する組成物
JP5051878B2 (ja) * 2007-03-02 2012-10-17 竹本油脂株式会社 高濃度セサミノール含有物の製造方法
EP2189160A4 (en) 2007-09-19 2010-10-13 Suntory Holdings Ltd COMPOSITION WITH A SESAMINE COMPONENT AND A VITAMIN B1 COMPONENT
CN113490422A (zh) * 2019-02-28 2021-10-08 株式会社笑颜 用于抑制/减少体重增加的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01104062A (ja) * 1987-10-16 1989-04-21 Taisho Pharmaceut Co Ltd テトラヒドロフラン誘導体
EP0818196B1 (en) * 1989-07-21 2004-12-29 Suntory Limited Capsule, containing dioxabicyclo(3.3.0)octane compounds

Also Published As

Publication number Publication date
EP0488513A3 (en) 1992-06-17
DE69119875D1 (de) 1996-07-04
DK0488513T3 (da) 1996-06-17
EP0488513B1 (en) 1996-05-29
DE69119875T2 (de) 1996-10-02
JP3183664B2 (ja) 2001-07-09
ES2087252T3 (es) 1996-07-16
JPH04159221A (ja) 1992-06-02
US5270335A (en) 1993-12-14
ATE138571T1 (de) 1996-06-15
CA2053820C (en) 1997-02-04
CA2053820A1 (en) 1992-04-23
EP0488513A2 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
GR3020682T3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
AU6128590A (en) Novel compounds
IL99889A0 (en) Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SG47437A1 (en) Composition containing dioxabicyclo (3.3.0) octane derivative
IE821779L (en) Pyridazine derivative.
IE893653L (en) Compositions and compounds
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
LTIP603A (en) Novel esters, method for the preparation thereof and pharmaceutical composition
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
EP0385446A3 (en) Osteogenesis promotion with use of vitamin d derivatives
HUT49887A (en) Process for producing new cefem compounds
SI0681788T1 (en) Dioxabicyclo(3.3.0) octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
DE69409874D1 (de) 16-Gliederige Makrolid-Derivate und Verfahren zu deren Herstellung
TW282470B (el)
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
IL65213A0 (en) Morpholine derivatives,their preparation and pharmaceutical compositions containing them
EP0308319A3 (en) 4-piperidinecarboxamide derivatives
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
AU4243689A (en) Antitumor substance, process for preparing the same and anticancer agent containing the same